View supplier listing 15% off with code KING15

Peptide guide

IGF-1 LR3 Peptide Guide & Supplier Listing Notes

Long-acting IGF-1 analog

Modified IGF-1 has reduced binding to IGF binding proteins and prolonged activity in models.

Growth hormone secretagogue research compounds Educational guide Supplier transparency

Back to directory Compare supplier pages

Educational disclaimer

Informational reference only

This page is for educational and informational purposes only. PeptideSuppliers.org does not sell peptides, provide medical advice, or recommend human use.

Overview

IGF-1 LR3, also called Long R3 IGF-1, is a modified analog of insulin-like growth factor 1. It is commonly discussed in research related to growth signaling, cell proliferation, tissue biology, and the GH/IGF-1 axis. Compared with native IGF-1, IGF-1 LR3 includes structural modifications intended to reduce binding to IGF-binding proteins and extend biological activity.

Because IGF-1 is a major downstream mediator of growth hormone, IGF-1 LR3 is often discussed near GH secretagogues such as sermorelin, CJC-1295, ipamorelin, and tesamorelin. However, it is mechanistically different because it is an IGF-1 analog rather than a compound that stimulates GH release.

IGF-1 LR3 should be handled carefully. It is biologically potent and often marketed aggressively, but the clearest educational framing focuses on receptor biology, binding-protein differences, and research context rather than broad muscle-growth claims.

Research snapshot

Quick research reference

Research Category: IGF-1 analog and growth-factor signaling research.

Primary Target: IGF-1 receptor signaling with altered binding to IGF-binding proteins.

Research Status: Specialized research compound with strong mechanistic relevance; human-use claims require caution.

Common Areas Studied: Cell growth, differentiation, tissue repair models, neurobiology, metabolism, and GH/IGF-1 axis research.

Related Compounds: IGF-1, IGF-1 DES, growth hormone, CJC-1295, sermorelin, tesamorelin, and ipamorelin.

Research overview

Use the linked literature searches for current papers and trial records.

Current summary

What research has looked at

Modified IGF-1 has reduced binding to IGF binding proteins and prolonged activity in models.

Evidence stage

How mature the research is

Mostly preclinical/research reagent use

Source links

Open current literature searches

Search PubMed Search ClinicalTrials.gov

Storage and handling notes

What clear supplier pages show

These pages are easier to trust when storage notes are easy to find, the format is clearly labeled, and batch documentation stays close to the listing.

Check whether the page clearly states the compound format being referenced.
Look for storage language that matches the label and any linked laboratory documentation.
Compare whether lot, batch, or COA references remain easy to access after the product details.
Note whether the page explains container, seal, or light-protection details in plain language.

Choosing a supplier page

What to compare when opening listings

Clear variant naming, signaling-family context, and easy-to-find laboratory documentation are the main things that should stand out when comparing supplier pages.

This listing becomes more useful when the reference differentiates it from other IGF entries and keeps the documentation language specific rather than repetitive.

Find this compound in the directory

Linked supplier pages

Use these pages to compare naming, documentation access, and overall page clarity.

Supplier listing

Peptides Kingdom

This listing is useful for checking naming, documentation access, and overall page clarity.

View supplier listing

15% off with code KING15

Related peptides

Use related pages to compare nearby compounds and adjacent research categories.

IGF-1 DES MK-677 CJC-1295

Frequently asked questions

Quick answers to the main questions that come up on this page.

What is IGF-1 LR3?

Long-acting IGF-1 analog

What research areas is it linked to?

IGF signaling, growth/metabolism cell culture and animal models

Mostly preclinical/research reagent use

What should stand out when comparing supplier pages?

Clear variant naming, signaling-family context, and easy-to-find laboratory documentation are the main things that should stand out when comparing supplier pages.